Leerink Partners Upgrades AN2 Therapeutics to Outperform, Announces $9 Price Target
AN2 Therapeutics Inc ANTX
$4.47
▼ -3.46%
($-0.16)
Open
$4.62
Prev Close
$4.63
Day Range
$4.41 – $4.74
52W Range
$1.00 – $6.91
Market Cap
$167.11M
Beta
-0.97
EPS (TTM)
$-1.10
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-03-25 |
| Shares Out. | 36,020,000 |
| Website | an2therapeutics.com/ ↗ |
| Phone | 16503319090 |
AN2 Therapeutics Inc is a publicly traded company under the ticker symbol ANTX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2026-05-01)